Has Aurobindo Pharma left its wild swings behind?
The Hyderabad-based generics maker has seen its stock scale all-time highs and lows in quick succession. With big plans in place and regulatory heat easing, its roller-coaster days may be over.
29 November, 2023•6 min
0
29 November, 2023•6 min
0
More in Business
Business
How SpiceJet and India’s legal system nearly killed the aircraft leasing business
Interminable delays and multiple out-of-court settlements later, the world’s leading lessors have tweaked their India playbook—stiffer terms, higher rentals. The fallout has hit aviation startups hard.
You may also like
Business
Natco just can’t kick its high-risk, high-gain game plan
CEO Rajeev Nannapaneni’s oft-used strategy of mounting patent challenges in the US got the pharma company its latest blockbuster Revlimid. But what after sales fall off a cliff?
Business
Wockhardt urgently needs Rs 400 crore and its two wonder drugs
A couple of antibiotics that have the potential to change the beleaguered company’s fortunes need a quick infusion of funds to get across the finish line. Can Khorakiwala, the 82-year-old chairman, pull it off?
Business
Laurus Labs is Indian pharma’s dark horse
With a promoter who is unafraid to make bold bets and pivot to businesses holding more promise, investors can only look forward to better times.